Lipid Trolling to Optimize A 3 Adenosine Receptor-Positive Allosteric Modulators (PAMs)
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Balaram Pradhan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institu…. Hauptthemen laut MEDLINE: Receptor, Adenosine A3, Adenosine A3 Receptor Agonists. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Intramural NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
A3 adenosine receptor (A3AR) positive allosteric modulators (PAMs) (2,4-disubstituted-1H-imidazo[4,5-c]quinolin-4-amines) allosterically increase the Emax of A3AR agonists, but not potency, due to concurrent orthosteric antagonism. Following mutagenesis/homology modeling of the proposed lipid-exposed allosteric binding site on the cytosolic side, we functionalized the scaffold, including heteroatom substitutions and exocyclic phenylamine extensions, to increase allosteric binding. Strategically appended linear alkyl-alkynyl chains with terminal amino/guanidino groups improved allosteric effects at both human and mouse A3ARs. The chain length, functionality, and attachment position were varied to modulate A3AR PAM activity. For example, 26 (MRS8247, p-alkyne-linked 8 methylenes) and homologues increased agonist Cl-IB-MECA's Emax and potency ([35S]GTPγS binding). The putative mechanism involves a flexible, terminally cationic chain penetrating the lipid environment for stable electrostatic anchoring to cytosolic phospholipid head groups, suggesting "lipid trolling", supported by molecular dynamic simulation of the active-state model. Thus, we have improved A3AR PAM activity through rational design based on an extrahelical, lipidic binding site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, United S…
- Department of Pharmacology & Toxicology and the Cardiovascular Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padua, 35131 Padua, Italy.
- Department of Biochemistry and the Program in Chemical Biology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, Wisconsin 53226, United States.
ORCID-Profile: Brian C Smith, John A Auchampach, Kenneth A Jacobson
Förderung
- NHLBI NIH HHS
- Intramural NIH HHS
- NIGMS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
- Medical College of Wisconsin
Zitieren
APA
Pradhan, B., Pavan, M., Fisher, C. L., Salmaso, V., Wan, T. C., Keyes, R. F., Rollison, N., Suresh, R. R., Kumar, T. S., Gao, Z. G., Smith, B. C., Auchampach, J. A., & Jacobson, K. A. (2024). Lipid Trolling to Optimize A 3 Adenosine Receptor-Positive Allosteric Modulators (PAMs). Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00944
Vancouver
Pradhan B, Pavan M, Fisher CL, Salmaso V, Wan TC, Keyes RF, et al. Lipid Trolling to Optimize A 3 Adenosine Receptor-Positive Allosteric Modulators (PAMs). Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00944
BibTeX
@article{Pradhan2024,
author = {Pradhan, Balaram and Pavan, Matteo and Fisher, Courtney L and Salmaso, Veronica and Wan, Tina C and Keyes, Robert F and Rollison, Noah and Suresh, R Rama and Kumar, T Santhosh and Gao, Zhan-Guo and Smith, Brian C and Auchampach, John A and Jacobson, Kenneth A},
title = {Lipid Trolling to Optimize A 3 Adenosine Receptor-Positive Allosteric Modulators (PAMs)},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00944}
}
EUVIMED